May 11, 2026 04:05PM
Apr 16, 2026 07:00AM
Mar 19, 2026 06:59AM
Mar 18, 2026 07:00AM
Mar 3, 2026 03:15PM
Mar 3, 2026 07:02AM
Mar 3, 2026 07:00AM Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication
Mar 2, 2026 04:05PM
Feb 17, 2026 07:00AM
Feb 3, 2026 05:00AM
Nov 18, 2025 07:01AM
Nov 18, 2025 07:00AM
Nov 10, 2025 04:05PM
Oct 6, 2025 07:00AM Harrow names Frank Mullery CEO of ImprimisRx subsidiary
Oct 6, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 26, 2025 07:00AM
Sep 23, 2025 06:45AM
Aug 11, 2025 04:01PM
Jul 17, 2025 07:00AM
Jul 17, 2025 07:00AM Samsung Bioepis Enters into a Partnership with Harrow for Commercialization of Ophthalmology Biosimilars Portfolio in the United States
Jul 17, 2025 07:00AM
Jun 11, 2025 04:25PM
Jun 9, 2025 07:03AM
Jun 9, 2025 07:00AM
May 8, 2025 04:01PM
Apr 10, 2025 07:00AM
Mar 27, 2025 04:01PM Harrow Announces Fourth-Quarter and Year-End 2024 Audited Financial Results
Mar 24, 2025 07:05AM
Mar 24, 2025 07:00AM
Mar 11, 2025 07:00AM
Feb 6, 2025 08:44AM
Jan 7, 2025 07:01AM
Jan 7, 2025 07:00AM
Nov 22, 2024 01:51PM OSRX, Inc. Responds to Jury Verdict in Trademark Infringement Case
Nov 20, 2024 07:00AM
Oct 18, 2024 06:10AM
Oct 10, 2024 07:00AM
Oct 3, 2024 07:02AM
Oct 3, 2024 07:00AM
Jul 29, 2024 08:00AM
Jul 9, 2024 07:02AM Harrow Health (HROW) Enters into 340B Prime Vendor Program Contract with Apexus for IHEEZO
Jul 9, 2024 07:00AM
Jun 20, 2024 07:04AM
Jun 20, 2024 07:00AM
Jun 6, 2024 08:00AM
Jun 5, 2024 07:00AM
Apr 2, 2024 08:16AM
Jan 11, 2024 07:02AM Harrow Health (HROW) Announces Availability of VEVYE 0.1%
Jan 11, 2024 07:00AM

322,090 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All